RightFit
RecruitingPhase not listed

Characterizing the Genomic Landscape of Cancer in Native American Populations (NAT-Geno)

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
18 Years to 100 Years
Sex
Male only
Healthy volunteers
Not accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

  • Procedures mentioned: Blood draws

Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.

Show the study's own words
  • "Archived tumor tissue collected at screening and peripheral blood samples obtained within the first year of enrollment will serve as the basis for comprehensive molecular analyses."
Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study looks at genes in stored tumor samples from Native American adults with certain cancers. Researchers want to learn how tumor genes may affect treatment choices, how cancer grows or spreads, and how patients do over time.

The purpose of this study is to analyze tumor tissue samples from patients of Native American identity with prespecified cancers of interest. By examining these samples, researchers hope to understand how different genes in your tumor can influence treatment decisions, how your cancer progresses and the outcome of your cancer.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Sign and date a consent form before any study tests, sample collection, or analysis.
  • Be at least 18 years old when signing the consent form.
  • Identify yourself as Native American.
  • Have a cancer diagnosis confirmed by lab testing, listed as PC or RCC in the study. Any stage is allowed.
  • Have your most recent stored tumor samples available.

Who can't join

  • Do not have Native American ancestry or identify as Native American.
  • Do not have stored tumor tissue available.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: * Written informed consent signed and dated by the patient prior to the performance of any study-specific procedures, sampling, or analyses. * At least 18 years-of-age at the time of signature of the informed consent form (ICF). * Patients who self-identify as Native American. * Patients with a pathologically proven diagnosis of PC and RCC (any stage). * Availability of most recent archived tumor samples. Exclusion Criteria: * Patients not of Native American descent or identity. * Patient does not have archival tissue available.

Study sites (1)

OK